Crestwood Advisors Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $212K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $245K | Buy |
|
|||||
|
2022
Q2 | $211K | Sell |
|
|||||
|
2022
Q1 | $631K | Sell |
|
|||||
|
2021
Q4 | $808K | Buy |
|
|||||
|
2021
Q3 | $896K | Sell |
|
|||||
|
2021
Q2 | $1.48M | Sell |
|
|||||
|
2021
Q1 | $1.72M | Buy |
|
|||||
|
2020
Q4 | $1.38M | Sell |
|
|||||
|
2020
Q3 | $1.1M | Buy |
|
|||||
|
2020
Q2 | $1.08M | Sell |
|
|||||
|
2020
Q1 | $752K | Sell |
|
|||||
|
2019
Q4 | $1.27M | Buy |
|
|||||
|
2019
Q3 | $990K | Sell |
|
|||||
|
2019
Q2 | $1.27M | Buy |
|
|||||
|
2019
Q1 | $1.28M | Sell |
|
|||||
|
2018
Q4 | $1.1M | Buy |
|
|||||
|
2018
Q3 | $743K | Hold |
|
|||||
|
2018
Q2 | $732K | Hold |
|
|||||
|
2018
Q1 | $680K | Hold |
|
|||||
|
2017
Q4 | $658K | Hold |
|
|||||
|
2017
Q3 | $671K | Hold |
|
|||||
|
2017
Q2 | $618K | Hold |
|
|||||
|
2017
Q1 | $549K | Hold |
|
|||||
|
2016
Q4 | $459K | Buy |
|
|||||
|
2016
Q3 | $249K | Hold |
|
|||||
|
2016
Q2 | $203K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $263K | Hold |
|
|||||
|
2015
Q3 | $233K | Hold |
|
|||||
|
2015
Q2 | $315K | Hold |
|
|||||
|
2015
Q1 | $282K | Hold |
|
|||||
|
2014
Q4 | $233K | Buy |
|